Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1994 May;160(5):440–446.

New insights into mechanisms of immune glomerular injury.

W G Couser 1
PMCID: PMC1022488  PMID: 8048228

Abstract

Although glomerular disease remains the most common cause of end-stage renal disease worldwide, major advances have been made recently in understanding the cellular and molecular mechanisms that mediate these disorders. The nephrotic syndrome in noninflammatory lesions such as minimal change or focal sclerosis and membranous nephropathy results from disorders of the glomerular epithelial cell that can be simulated in animal models by antibodies to various epithelial cell membrane epitopes. Clarification of how these antibodies affect epithelial cells to induce a loss of glomerular barrier function should substantially improve understanding of the pathogenesis of minimal change or focal sclerosis. In membranous nephropathy, proteinuria is mediated primarily by the C5b-9 complex through similar mechanisms that also involve glomerular epithelial cells as targets. Inflammatory glomerular lesions are induced by circulating inflammatory cells or proliferating resident glomerular cells. Understanding of how these cells induce tissue injury has also evolved considerably over the past decade. Neutrophil-induced disease involves leukocyte adhesion molecules in regulating neutrophil localization; proteases, oxidants, and myeloperoxidase in mediating injury; and platelets in augmenting these processes. The activated mesangial cell exhibits altered phenotype and proliferation with the release of oxidants and proteases. Mesangial cell proliferation may be initiated by basic fibroblast growth factor and is maintained by an autocrine mechanism involving platelet-derived growth factor. Transforming growth factor beta is important in the subsequent development of sclerosis.

Full text

PDF
440

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abboud H. E. Growth factors in glomerulonephritis. Kidney Int. 1993 Jan;43(1):252–267. doi: 10.1038/ki.1993.39. [DOI] [PubMed] [Google Scholar]
  2. Abboud H. E. Resident glomerular cells in glomerular injury: mesangial cells. Semin Nephrol. 1991 May;11(3):304–311. [PubMed] [Google Scholar]
  3. Adler S., Baker P. J., Johnson R. J., Ochi R. F., Pritzl P., Couser W. G. Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest. 1986 Mar;77(3):762–767. doi: 10.1172/JCI112372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Adler S. Integrin receptors in the glomerulus: potential role in glomerular injury. Am J Physiol. 1992 May;262(5 Pt 2):F697–F704. doi: 10.1152/ajprenal.1992.262.5.F697. [DOI] [PubMed] [Google Scholar]
  5. Adler S. Integrin receptors in the glomerulus: potential role in glomerular injury. Am J Physiol. 1992 May;262(5 Pt 2):F697–F704. doi: 10.1152/ajprenal.1992.262.5.F697. [DOI] [PubMed] [Google Scholar]
  6. Baker P. J., Ochi R. F., Schulze M., Johnson R. J., Campbell C., Couser W. G. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am J Pathol. 1989 Jul;135(1):185–194. [PMC free article] [PubMed] [Google Scholar]
  7. Bhan A. K., Schneeberger E. E., Collins A. B., McCluskey R. T. Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J Exp Med. 1978 Jul 1;148(1):246–260. doi: 10.1084/jem.148.1.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bolton W. K., Chandra M., Tyson T. M., Kirkpatrick P. R., Sadovnic M. J., Sturgill B. C. Transfer of experimental glomerulonephritis in chickens by mononuclear cells. Kidney Int. 1988 Nov;34(5):598–610. doi: 10.1038/ki.1988.224. [DOI] [PubMed] [Google Scholar]
  9. Border W. A., Noble N. A., Yamamoto T., Tomooka S., Kagami S. Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int. 1992 Mar;41(3):566–570. doi: 10.1038/ki.1992.83. [DOI] [PubMed] [Google Scholar]
  10. Border W. A., Noble N. A., Yamamoto T., Tomooka S., Kagami S. Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int. 1992 Mar;41(3):566–570. doi: 10.1038/ki.1992.83. [DOI] [PubMed] [Google Scholar]
  11. Border W. A., Okuda S., Languino L. R., Sporn M. B., Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature. 1990 Jul 26;346(6282):371–374. doi: 10.1038/346371a0. [DOI] [PubMed] [Google Scholar]
  12. Boyce N. W., Holdsworth S. R. Direct antiGBM antibody induced alterations in glomerular permselectivity. Kidney Int. 1986 Nov;30(5):666–672. doi: 10.1038/ki.1986.238. [DOI] [PubMed] [Google Scholar]
  13. Boyce N. W., Tipping P. G., Holdsworth S. R. Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis. Kidney Int. 1986 Nov;30(5):673–677. doi: 10.1038/ki.1986.239. [DOI] [PubMed] [Google Scholar]
  14. Briscoe D. M., Cotran R. S. Role of leukocyte-endothelial cell adhesion molecules in renal inflammation: in vitro and in vivo studies. Kidney Int Suppl. 1993 Jul;42:S27–S34. [PubMed] [Google Scholar]
  15. Brouwer E., Huitema M. G., Klok P. A., de Weerd H., Tervaert J. W., Weening J. J., Kallenberg C. G. Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med. 1993 Apr 1;177(4):905–914. doi: 10.1084/jem.177.4.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. COCHRANE C. G., UNANUE E. R., DIXON F. J. A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS. J Exp Med. 1965 Jul 1;122:99–116. doi: 10.1084/jem.122.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cosio F. G. Cell-matrix adhesion receptors: relevance to glomerular pathology. Am J Kidney Dis. 1992 Sep;20(3):294–305. doi: 10.1016/s0272-6386(12)80705-0. [DOI] [PubMed] [Google Scholar]
  18. Couser W. G., Abrass C. K. Pathogenesis of membranous nephropathy. Annu Rev Med. 1988;39:517–530. doi: 10.1146/annurev.me.39.020188.002505. [DOI] [PubMed] [Google Scholar]
  19. Couser W. G., Baker P. J., Adler S. Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int. 1985 Dec;28(6):879–890. doi: 10.1038/ki.1985.214. [DOI] [PubMed] [Google Scholar]
  20. Couser W. G., Darby C., Salant D. J., Adler S., Stilmant M. M., Lowenstein L. M. Anti-GBM antibody-induced proteinuria in isolated perfused rat kidney. Am J Physiol. 1985 Aug;249(2 Pt 2):F241–F250. doi: 10.1152/ajprenal.1985.249.2.F241. [DOI] [PubMed] [Google Scholar]
  21. Couser W. G. Mechanisms of glomerular injury in immune-complex disease. Kidney Int. 1985 Sep;28(3):569–583. doi: 10.1038/ki.1985.167. [DOI] [PubMed] [Google Scholar]
  22. Couser W. G. Mediation of immune glomerular injury. J Am Soc Nephrol. 1990 Jul;1(1):13–29. doi: 10.1681/ASN.V1113. [DOI] [PubMed] [Google Scholar]
  23. Couser W. G., Schulze M., Pruchno C. J. Role of C5b-9 in experimental membranous nephropathy. Nephrol Dial Transplant. 1992;7 (Suppl 1):25–31. [PubMed] [Google Scholar]
  24. Cybulsky A. V., Bonventre J. V., Quigg R. J., Lieberthal W., Salant D. J. Cytosolic calcium and protein kinase C reduce complement-mediated glomerular epithelial injury. Kidney Int. 1990 Nov;38(5):803–811. doi: 10.1038/ki.1990.274. [DOI] [PubMed] [Google Scholar]
  25. Cybulsky A. V., Quigg R. J., Salant D. J. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy. J Immunol. 1986 Sep 1;137(5):1511–1516. [PubMed] [Google Scholar]
  26. Cybulsky A. V., Salant D. J., Quigg R. J., Badalamenti J., Bonventre J. V. Complement C5b-9 complex activates phospholipases in glomerular epithelial cells. Am J Physiol. 1989 Nov;257(5 Pt 2):F826–F836. doi: 10.1152/ajprenal.1989.257.5.F826. [DOI] [PubMed] [Google Scholar]
  27. Floege J., Alpers C. E., Burns M. W., Pritzl P., Gordon K., Couser W. G., Johnson R. J. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest. 1992 Apr;66(4):485–497. [PubMed] [Google Scholar]
  28. Floege J., Alpers C. E., Sage E. H., Pritzl P., Gordon K., Johnson R. J., Couser W. G. Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest. 1992 Oct;67(4):486–497. [PubMed] [Google Scholar]
  29. Floege J., Burns M. W., Alpers C. E., Yoshimura A., Pritzl P., Gordon K., Seifert R. A., Bowen-Pope D. F., Couser W. G., Johnson R. J. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int. 1992 Feb;41(2):297–309. doi: 10.1038/ki.1992.42. [DOI] [PubMed] [Google Scholar]
  30. Floege J., Eng E., Lindner V., Alpers C. E., Young B. A., Reidy M. A., Johnson R. J. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest. 1992 Dec;90(6):2362–2369. doi: 10.1172/JCI116126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Floege J., Eng E., Young B. A., Alpers C. E., Barrett T. B., Bowen-Pope D. F., Johnson R. J. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest. 1993 Dec;92(6):2952–2962. doi: 10.1172/JCI116918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Floege J., Eng E., Young B. A., Johnson R. J. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int Suppl. 1993 Jan;39:S47–S54. [PubMed] [Google Scholar]
  33. Floege J., Johnson R. J., Gordon K., Iida H., Pritzl P., Yoshimura A., Campbell C., Alpers C. E., Couser W. G. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int. 1991 Sep;40(3):477–488. doi: 10.1038/ki.1991.235. [DOI] [PubMed] [Google Scholar]
  34. Floege J., Johnson R. J., Gordon K., Yoshimura A., Campbell C., Iruela-Arispe L., Alpers C. E., Couser W. G. Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy. Kidney Int. 1992 Sep;42(3):573–585. doi: 10.1038/ki.1992.321. [DOI] [PubMed] [Google Scholar]
  35. Floege J., Topley N., Hoppe J., Barrett T. B., Resch K. Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol. 1991 Nov;86(2):334–341. doi: 10.1111/j.1365-2249.1991.tb05819.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Gesualdo L., Pinzani M., Floriano J. J., Hassan M. O., Nagy N. U., Schena F. P., Emancipator S. N., Abboud H. E. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest. 1991 Aug;65(2):160–167. [PubMed] [Google Scholar]
  37. Hancock W. W., Atkins R. C. Cellular composition of crescents in human rapidly progressive glomerulonephritis identified using monoclonal antibodies. Am J Nephrol. 1984;4(3):177–181. doi: 10.1159/000166800. [DOI] [PubMed] [Google Scholar]
  38. Holdsworth S. R., Neale T. J., Wilson C. B. Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest. 1981 Sep;68(3):686–698. doi: 10.1172/JCI110304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Holdsworth S. R., Tipping P. G. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest. 1985 Oct;76(4):1367–1374. doi: 10.1172/JCI112112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Iida H., Seifert R., Alpers C. E., Gronwald R. G., Phillips P. E., Pritzl P., Gordon K., Gown A. M., Ross R., Bowen-Pope D. F. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6560–6564. doi: 10.1073/pnas.88.15.6560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Johnson R. J., Alpers C. E., Pritzl P., Schulze M., Baker P., Pruchno C., Couser W. G. Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest. 1988 Oct;82(4):1225–1235. doi: 10.1172/JCI113720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Johnson R. J., Alpers C. E., Pruchno C., Schulze M., Baker P. J., Pritzl P., Couser W. G. Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis. Kidney Int. 1989 Nov;36(5):780–789. doi: 10.1038/ki.1989.263. [DOI] [PubMed] [Google Scholar]
  43. Johnson R. J., Couser W. G., Alpers C. E., Vissers M., Schulze M., Klebanoff S. J. The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med. 1988 Sep 1;168(3):1169–1174. doi: 10.1084/jem.168.3.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Johnson R. J., Couser W. G., Chi E. Y., Adler S., Klebanoff S. J. New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest. 1987 May;79(5):1379–1387. doi: 10.1172/JCI112965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Johnson R. J., Floege J., Couser W. G., Alpers C. E. Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol. 1993 Aug;4(2):119–128. doi: 10.1681/ASN.V42119. [DOI] [PubMed] [Google Scholar]
  46. Johnson R. J., Garcia R. L., Pritzl P., Alpers C. E. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol. 1990 Feb;136(2):369–374. [PMC free article] [PubMed] [Google Scholar]
  47. Johnson R. J., Guggenheim S. J., Klebanoff S. J., Ochi R. F., Wass A., Baker P., Schulze M., Couser W. G. Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidase-hydrogen peroxide-halide system of the neutrophil. Lab Invest. 1988 Mar;58(3):294–301. [PubMed] [Google Scholar]
  48. Johnson R. J., Iida H., Alpers C. E., Majesky M. W., Schwartz S. M., Pritzi P., Gordon K., Gown A. M. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest. 1991 Mar;87(3):847–858. doi: 10.1172/JCI115089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Johnson R. J., Klebanoff S. J., Ochi R. F., Adler S., Baker P., Sparks L., Couser W. G. Participation of the myeloperoxidase-H2O2-halide system in immune complex nephritis. Kidney Int. 1987 Sep;32(3):342–349. doi: 10.1038/ki.1987.215. [DOI] [PubMed] [Google Scholar]
  50. Johnson R. J., Lovett D., Lehrer R. I., Couser W. G., Klebanoff S. J. Role of oxidants and proteases in glomerular injury. Kidney Int. 1994 Feb;45(2):352–359. doi: 10.1038/ki.1994.45. [DOI] [PubMed] [Google Scholar]
  51. Johnson R. J. Platelets in inflammatory glomerular injury. Semin Nephrol. 1991 May;11(3):276–284. [PubMed] [Google Scholar]
  52. Johnson R. J. Platelets in inflammatory glomerular injury. Semin Nephrol. 1991 May;11(3):276–284. [PubMed] [Google Scholar]
  53. Johnson R. J., Pritzl P., Iida H., Alpers C. E. Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol. 1991 Feb;138(2):313–321. [PMC free article] [PubMed] [Google Scholar]
  54. Johnson R. J., Raines E. W., Floege J., Yoshimura A., Pritzl P., Alpers C., Ross R. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med. 1992 May 1;175(5):1413–1416. doi: 10.1084/jem.175.5.1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Johnson R., Iida H., Yoshimura A., Floege J., Bowen-Pope D. F. Platelet-derived growth factor: a potentially important cytokine in glomerular disease. Kidney Int. 1992 Mar;41(3):590–594. doi: 10.1038/ki.1992.88. [DOI] [PubMed] [Google Scholar]
  56. Johnson R., Yamabe H., Chen Y. P., Campbell C., Gordon K., Baker P., Lovett D., Couser W. G. Glomerular epithelial cells secrete a glomerular basement membrane-degrading metalloproteinase. J Am Soc Nephrol. 1992 Mar;2(9):1388–1397. doi: 10.1681/ASN.V291388. [DOI] [PubMed] [Google Scholar]
  57. Kanwar Y. S., Liu Z. Z., Kashihara N., Wallner E. I. Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol. 1991 Jul;11(4):390–413. [PubMed] [Google Scholar]
  58. Kerjaschki D., Schulze M., Binder S., Kain R., Ojha P. P., Susani M., Horvat R., Baker P. J., Couser W. G. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol. 1989 Jul 15;143(2):546–552. [PubMed] [Google Scholar]
  59. Kerjaschki D. The pathogenesis of membranous glomerulonephritis: from morphology to molecules. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;58(4):253–271. doi: 10.1007/BF02890080. [DOI] [PubMed] [Google Scholar]
  60. Koyama A., Fujisaki M., Kobayashi M., Igarashi M., Narita M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int. 1991 Sep;40(3):453–460. doi: 10.1038/ki.1991.232. [DOI] [PubMed] [Google Scholar]
  61. Lovett D. H., Johnson R. J., Marti H. P., Martin J., Davies M., Couser W. G. Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol. 1992 Jul;141(1):85–98. [PMC free article] [PubMed] [Google Scholar]
  62. Main I. W., Nikolic-Paterson D. J., Atkins R. C. T cells and macrophages and their role in renal injury. Semin Nephrol. 1992 Sep;12(5):395–407. [PubMed] [Google Scholar]
  63. Mendrick D. L., Rennke H. G. Epitope specific induction of proteinuria by monoclonal antibodies. Kidney Int. 1988 Apr;33(4):831–842. doi: 10.1038/ki.1988.74. [DOI] [PubMed] [Google Scholar]
  64. Mendrick D. L., Rennke H. G. Induction of proteinuria in the rat by a monoclonal antibody against SGP-115/107. Kidney Int. 1988 Apr;33(4):818–830. doi: 10.1038/ki.1988.73. [DOI] [PubMed] [Google Scholar]
  65. Nathan C. F. Secretory products of macrophages. J Clin Invest. 1987 Feb;79(2):319–326. doi: 10.1172/JCI112815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Neale T. J., Ullrich R., Ojha P., Poczewski H., Verhoeven A. J., Kerjaschki D. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3645–3649. doi: 10.1073/pnas.90.8.3645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Orikasa M., Matsui K., Oite T., Shimizu F. Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol. 1988 Aug 1;141(3):807–814. [PubMed] [Google Scholar]
  68. Quigg R. J., Cybulsky A. V., Jacobs J. B., Salant D. J. Anti-Fx1A produces complement-dependent cytotoxicity of glomerular epithelial cells. Kidney Int. 1988 Jul;34(1):43–52. doi: 10.1038/ki.1988.143. [DOI] [PubMed] [Google Scholar]
  69. Raines E. W., Lane T. F., Iruela-Arispe M. L., Ross R., Sage E. H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1281–1285. doi: 10.1073/pnas.89.4.1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Salant D. J., Adler S., Darby C., Capparell N. J., Groggel G. C., Feintzeig I. D., Rennke H. G., Dittmer J. E. Influence of antigen distribution on the mediation of immunological glomerular injury. Kidney Int. 1985 Jun;27(6):938–950. doi: 10.1038/ki.1985.102. [DOI] [PubMed] [Google Scholar]
  71. Salant D. J., Belok S., Madaio M. P., Couser W. G. A new role for complement in experimental membranous nephropathy in rats. J Clin Invest. 1980 Dec;66(6):1339–1350. doi: 10.1172/JCI109987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Salant D. J., Madaio M. P., Adler S., Stilmant M. M., Couser W. G. Altered glomerular permeability induced by F(ab')2 and Fab' antibodies to rat renal tubular epithelial antigen. Kidney Int. 1982 Jan;21(1):36–43. doi: 10.1038/ki.1982.6. [DOI] [PubMed] [Google Scholar]
  73. Savin V. J. Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis. 1993 Apr;21(4):347–362. doi: 10.1016/s0272-6386(12)80260-5. [DOI] [PubMed] [Google Scholar]
  74. Schreiner G. F., Cotran R. S., Pardo V., Unanue E. R. A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med. 1978 Feb 1;147(2):369–384. doi: 10.1084/jem.147.2.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Sedor J. R., Konieczkowski M., Huang S., Gronich J. H., Nakazato Y., Gordon G., King C. H. Cytokines, mesangial cell activation and glomerular injury. Kidney Int Suppl. 1993 Jan;39:S65–S70. [PubMed] [Google Scholar]
  76. Shah S. V. Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol. 1988 Mar;254(3 Pt 2):F337–F344. doi: 10.1152/ajprenal.1988.254.3.F337. [DOI] [PubMed] [Google Scholar]
  77. Shah S. V. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int. 1989 May;35(5):1093–1106. doi: 10.1038/ki.1989.96. [DOI] [PubMed] [Google Scholar]
  78. Tipping P. G., Holdsworth S. R. The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits. Am J Pathol. 1986 Jul;124(1):10–17. [PMC free article] [PubMed] [Google Scholar]
  79. Tipping P. G., Neale T. J., Holdsworth S. R. T lymphocyte participation in antibody-induced experimental glomerulonephritis. Kidney Int. 1985 Mar;27(3):530–537. doi: 10.1038/ki.1985.43. [DOI] [PubMed] [Google Scholar]
  80. Tipping P. G., Worthington L. A., Holdsworth S. R. Quantitation and characterization of glomerular procoagulant activity in experimental glomerulonephritis. Lab Invest. 1987 Feb;56(2):155–159. [PubMed] [Google Scholar]
  81. Torbohm I., Schönermark M., Wingen A. M., Berger B., Rother K., Hänsch G. M. C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells. Kidney Int. 1990 Apr;37(4):1098–1104. doi: 10.1038/ki.1990.91. [DOI] [PubMed] [Google Scholar]
  82. Venkatachalam M. A., Karnovsky M. J., Cotran R. S. Glomerular permeability. Ultrastructural studies in experimental nephrosis using horseradish peroxidase as a tracer. J Exp Med. 1969 Aug 1;130(2):381–399. doi: 10.1084/jem.130.2.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Watanabe K., Kinoshita S., Nakagawa H. Gelatinase secretion by glomerular epithelial cells. Nephron. 1990;56(4):405–409. doi: 10.1159/000186184. [DOI] [PubMed] [Google Scholar]
  84. Yoshimura A., Gordon K., Alpers C. E., Floege J., Pritzl P., Ross R., Couser W. G., Bowen-Pope D. F., Johnson R. J. Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int. 1991 Sep;40(3):470–476. doi: 10.1038/ki.1991.234. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES